Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;29(4):100504.
doi: 10.1016/j.jnha.2025.100504. Epub 2025 Feb 13.

Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health

Affiliations

Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health

Ruixin Zhu et al. J Nutr Health Aging. 2025 Apr.

Abstract

Objectives: The American Heart Association defined cardiovascular-kidney-metabolic (CKM) syndrome as a novel multi-stage disorder. We examined the associations of CKM stages with premature mortality and the role of social determinants of health (SDOHs).

Design: A prospective cohort study.

Setting and participants: A nationally representative sample of US adults from NHANES 1999-2018.

Measurements: CKM included 5 stages (stages 0-4), reflecting progressive pathophysiology. Premature mortality (deaths before 75 years) were ascertained via linkage to the National Death Index with follow-up until 2019. Cox proportional-hazards models adjusted for age, sex, race/ethnicity, medical history, and other confounding factors were used to calculate the hazard ratios (HR) and 95% CIs for CKM-mortality associations.

Results: Among 27,909 participants (mean age 49.7 years, 49.0% females), 1762 premature deaths occurred over a median follow-up of 8.3 years. Compared with stage 0, the adjusted HRs for all-cause premature mortality at CKM stages 1-4 were 0.88 (95% CI 0.66-1.17), 1.31 (0.99-1.73), 1.94 (1.31-2.87), and 2.19 (1.61-2.98), respectively. For CVD premature mortality, the adjusted HRs for CKM stages 1-4 were 1.12 (0.46-2.72), 1.74 (0.71-4.28), 3.93 (1.53-10.12), and 6.48 (2.95-14.20), respectively. Among adults at CKM stages 3-4, unfavorable SDOHs, particularly not living with a partner, low family income, lack of private health insurance, unemployment, or ≥2 cumulative SDOHs (4.16, 95% CI 3.35-5.18) were associated with increased all-cause premature mortality. Among those at CKM stages 0-2, unfavorable SDOHs were also related to increased premature mortality.

Conclusion: CKM stages 3-4, but not stages 1-2, were associated with increased risks of premature mortality compared with stage 0. The risks were increased by unfavorable SDOHs across CKM stages.

Keywords: Cardiovascular disease; Cardiovascular–kidney–metabolic health; Diabetes; Health disparities; Obesity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Adjusted hazard ratios for risk of premature mortality from all causes and cardiovascular disease according to cardiovascular–kidney–metabolic syndrome stages by cumulative unfavorable social determinants of health. Abbreviations: SDOHs, social determinants of health; CKM, cardiovascular–kidney–metabolic syndrome; HR, hazard ratio; CI, confidence interval. Points represent HRs and error bars represent 95% CIs. No adjustments of multiple comparisons were applied. All estimates accounted for complex survey designs. Models were adjusted for baseline age, sex, race/ethnicity, alcohol consumption, smoking status, physical activity, and medical history of cancer at baseline.
Fig. 2
Fig. 2
Adjusted hazard ratios for risk of all-cause premature mortality according to cardiovascular–kidney–metabolic syndrome stages by social determinants of health. Abbreviations: SDOHs, social determinants of health; CKM, cardiovascular–kidney–metabolic syndrome; HR, hazard ratio; CI, confidence interval. Points represent HRs and error bars represent 95% CIs. No adjustments of multiple comparisons were applied. All estimates accounted for complex survey designs. Models were adjusted for baseline age, sex, race/ethnicity, education, marital status, family income-to-poverty ratio, food security, type of health insurance, employment status, home ownership, regular health-care access, alcohol consumption, smoking status, physical activity, and medical history of cancer at baseline if applicable.
Fig. 3
Fig. 3
Adjusted hazard ratios for risk of premature mortality from cardiovascular disease according to cardiovascular–kidney–metabolic syndrome stages by social determinants of health. Abbreviations: SDOHs, social determinants of health; CKM, cardiovascular–kidney–metabolic syndrome; HR, hazard ratio; CI, confidence interval. Points represent HRs and error bars represent 95% CIs. No adjustments of multiple comparisons were applied. All estimates accounted for complex survey designs. Models were adjusted for baseline age, sex, race/ethnicity, education, marital status, family income-to-poverty ratio, food security, type of health insurance, employment status, home ownership, regular health-care access, alcohol consumption, smoking status, physical activity, and medical history of cancer at baseline if applicable.

Similar articles

Cited by

References

    1. Ndumele C.E., Rangaswami J., Chow S.L., Neeland I.J., Tuttle K.R., Khan S.S., et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148:1606–1635. doi: 10.1161/CIR.0000000000001184. - DOI - PubMed
    1. Aggarwal R., Ostrominski J.W., Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US Adults, 2011–2020. JAMA. 2024;331(21):1858–1860. doi: 10.1001/jama.2024.6892. Published online 08 May 2024. - DOI - PMC - PubMed
    1. Zhu R., Wang R., He J., Wang L., Chen H., Niu X., et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health. JAMA Netw Open. 2024;7:e2445309. doi: 10.1001/jamanetworkopen.2024.45309. - DOI - PMC - PubMed
    1. Chen A., He Q., Wu Y., Chen J., Ma X., Hu L., et al. Incidence of cardiovascular-kidney-metabolic syndrome and its risk factors for progression in China. medRxiv. 2024 doi: 10.1101/2024.08.07.24311650. 2024.08.07.24311650. - DOI
    1. Diseases G.B.D., Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–2161. doi: 10.1016/S0140-6736(24)00757-8. - DOI - PMC - PubMed